Hassett: White House may review AI models ‘like an FDA drug’
National Economic Council Director Kevin Hassett said Wednesday the White House is considering an executive order that would require AI models to go through an evaluation process similar to that used by the Food and Drug Administration (FDA). The potential order comes as the Trump administration is grappling with Mythos, a new advanced AI model…
Original Source
Read the full article at Thehill →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.